A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia - ScienceDirect

Inhibition of the Menin (MEN1) and MLL (MLL1, KMT2A) interaction is a potential therapeutic strategy for MLL-rearranged (MLL-r) leukemia. Structure-ba…

Novel therapeutic strategies for MLL-rearranged leukemias

High-Affinity Small-Molecule Inhibitors of the Menin-Mixed Lineage

Discovery of M-1121 as an Orally Active Covalent Inhibitor of

Mechanisms of myeloid leukemogenesis: Current perspectives and

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors

Learning from mouse models of MLL fusion gene-driven acute

Biochemical perspectives on targeting KMT2 methyltransferases in

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors

A molecular switch between mammalian MLL complexes dictates

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors

MLL::AF9 degradation induces rapid changes in transcriptional

A Menin-MLL Inhibitor Induces Specific Chromatin Changes and

Frontiers Rewiring the Epigenetic Networks in MLL-Rearranged

The menin-MLL1 interaction is a molecular dependency in NUP98